{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:04:53Z","timestamp":1776834293126,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.biopsych.2012.04.030","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T19:08:47Z","timestamp":1338923327000},"page":"548-554","source":"Crossref","is-referenced-by-count":57,"title":["Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder"],"prefix":"10.1016","volume":"72","author":[{"given":"Masahiro","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina S.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami S.","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan G.","family":"Mallinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah P.","family":"Dickstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeih-San","family":"Liow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor W.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne C.","family":"Drevets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.04.030_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-8993(94)91552-0","article-title":"Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims","volume":"633","author":"Cowburn","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.04.030_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-0327(99)00048-8","article-title":"Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims","volume":"56","author":"Reiach","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2012.04.030_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/appi.ajp.159.1.66","article-title":"[3H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims","volume":"159","author":"Dwivedi","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.030_bib4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(05)79827-5","article-title":"Increased temporal cortex CREB concentrations and antidepressant treatment in major depression","volume":"352","author":"Dowlatshahi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2012.04.030_bib5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.030_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.030_bib7","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1054-3589(08)60128-3","article-title":"The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: Intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions","author":"Houslay","year":"1998"},{"key":"10.1016\/j.biopsych.2012.04.030_bib8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1046\/j.1471-4159.1997.69062397.x","article-title":"Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain","volume":"69","author":"Ye","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2012.04.030_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/bjp.2008.56","article-title":"Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells","volume":"154","author":"Campos-Toimil","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2012.04.030_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/syn.10013","article-title":"Facilitation of dopaminergic neural transmission does not affect [11C]SCH23390 binding to the striatal D1 dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D1 receptors: PET studies in the conscious monkey brain","volume":"42","author":"Tsukada","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2012.04.030_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj3330139","article-title":"cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model","volume":"333","author":"Hoffmann","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2012.04.030_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/syn.20728","article-title":"Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats","volume":"64","author":"Itoh","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2012.04.030_bib13","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P)","author":"First","year":"2001"},{"key":"10.1016\/j.biopsych.2012.04.030_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.030_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.030_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.biopsych.2012.04.030_bib17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.neuroimage.2010.10.064","article-title":"Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: A retest study and use of an image-derived input function","volume":"54","author":"Zanotti-Fregonara","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2012.04.030_bib18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2012.04.030_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2012.04.030_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","article-title":"Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects","volume":"12","author":"M\u00fcller-G\u00e4tner","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2012.04.030_bib21","series-title":"Positron Emission Tomography Basic Science and Clinical Practice","article-title":"Tracer kinetic modeling in PET","author":"Carson","year":"2003"},{"key":"10.1016\/j.biopsych.2012.04.030_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/S1461145709009894","article-title":"Locally increased P-glycoprotein function in major depression: A PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier","volume":"12","author":"de Klerk","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.04.030_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0773.1983.tb03432.x","article-title":"Cyclic AMP phosphodiesterase activity in rat brain following chronic treatment with lithium, imipramine, reserpine, and combinations of lithium with imipramine or reserpine","volume":"53","author":"Andersen","year":"1983","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.biopsych.2012.04.030_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1523\/JNEUROSCI.19-02-00610.1999","article-title":"Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms","volume":"19","author":"Takahashi","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.04.030_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000118897","article-title":"A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder","volume":"26","author":"Fleischhacker","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2012.04.030_bib26","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/138161209788168092","article-title":"Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs","volume":"15","author":"Zhang","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2012.04.030_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O'Donnell","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2012.04.030_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.04.030_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat Biotechnol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312004143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312004143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T11:19:15Z","timestamp":1561807155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312004143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0006322312004143"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.04.030","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}